The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWPP Regulatory News (WPP)

Share Price Information for WPP (WPP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 812.60
Bid: 814.00
Ask: 814.40
Change: 8.40 (1.04%)
Spread: 0.40 (0.049%)
Open: 804.20
High: 821.60
Low: 804.20
Prev. Close: 804.20
WPP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EPSP 2013 - 17

14 Mar 2018 15:52

RNS Number : 7524H
WPP PLC
14 March 2018
 

For Immediate Release

14 March 2018

 

WPP PLC ("WPP")

 

EPSP 2013 - 17

 

· WPP's Executive Performance Share Plan ("EPSP") is the performance-based, management incentive compensation plan designed to incentivise long-term performance and to focus on long-term retention and strategic priorities.

· First five-year outcome under the EPSP which was designed following shareowner consultation and approved by shareowners in June 2013

· Measures performance achievement equally across three key areas; earnings growth, capital effectiveness and share price growth using EPS growth, Return-on-Equity, Relative TSR metrics.

· Relates to five-year performance period 2013-17 over which:

o Market capitalisation increased by 51.6% from £11.23bn to £17.03bn while the FTSE 100 rose by 30.3%

o £1,000 invested in WPP on 1 January 2013 increased to £1,510 by end of 2017 compared with £1,303 if invested in the FTSE 100

o EPS grew by 64.0% from 73.4p to 120.4p - a CAGR of 10.4%

o RoE averaged 15.8%

· Share price weakness to date, post the 2013-17 performance period, has been reflected in the value received by executives in the current awards vesting and will be in future cycles of the EPSP.

 

 

Introduction

WPP's EPSP was approved by shareowners in June 2013 and today's announcement is the first five-year outcome under the EPSP. The arithmetic application of the EPSP metrics has resulted in a vesting of 72.8% of the maximum.

 

The outcome results in the vesting of 858,730 shares for Sir Martin Sorrell, CEO, which were valued at £10.0m at the vesting price of £11.655435 per share on 13 March 2018.

 

This covers a five-year performance period in which the FTSE 100 rose 30.3% while WPP's shares rose 51.0%. £1,000 invested in WPP at the start of the period increased to £1,510 by the end of 2017 compared with £1,303 if invested in the FTSE 100. WPP's market capitalisation increased by 51.6% to £17.03 billion ($23.0 billion). The decline in WPP's share price since the end of the 2013-17 performance period has been reflected in the value received by executives in the current awards vesting and will be in future cycles of the EPSP.

 

 

Directors' Interests

On 13 March 2018 Sir Martin Sorrell exercised his option to receive 858,730 shares which vested pursuant to his award granted under the EPSP in 2013. On 13 March 2018 Sir Martin Sorrell sold 401,771 of these shares to raise £4.68m to discharge the consequential tax liabilities.

 

At today's date Sir Martin Sorrell and his family interests are interested in or have rights in 18,540,315 shares. Sir Martin Sorrell's family interests and rights represent 1.463% of the issued share capital of WPP. Additionally the JMCMRJ Sorrell Foundation holds 4,575,936 WPP shares, representing 0.361% of WPP's issued share capital.

 

On 13 March 2018 Mr Paul Richardson, CFO, exercised his option to receive the shares which vested pursuant to the award granted under the EPSP in 2013 in relation to 216,600 shares and sold all of these shares after exercise.

 

At today's date Mr Paul Richardson's beneficial holding is the equivalent of 1,068,240 shares (all being in WPP ADRs), representing 0.084% of WPP's issued share capital.

 

 

 

For further information please contact:

 

Richard Oldworth, Buchanan

+44 (0)207 466 5000 or +44 (0)7710 130 634

 

 

 

 

Notes to Editors

 

· The participants include the two Executive Directors as disclosed in this announcement and many of the senior executives responsible for some of the Group's largest operating companies.

· Over the performance period 2013-2017 share owner value has been created by:

Market capitalisation increasing by £5.8bn ($4.7bn)

Dividends of £2.772bn ($4.018bn) - representing 16.1% CAGR in dividend per share from 28.51p to 60.0p

Share buy-backs of £2.227bn ($3.277bn)

 

Key Financials 2013-17

 

2012

2017

Increase (%)

CAGR (%)

Revenue (£'m)

10,373

15,265

47.2

8.0

Revenue less Pass-Through Costs (£'m)

9,515

13,140

38.1

6.7

P.B.I.T (£'m)

1,531

2,267

48.1

8.2

Headline Diluted EPS (p)

73.4

120.4

64.0

10.4

Dividend (p)

28.51

60.0

110.5

16.1

Share Price (p)

888

1,341

51.0

 

Market Capitalisation (£'bn)

11.23

17.03

51.6

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUSSVRWWAOAAR
Date   Source Headline
2nd Feb 202111:58 amRNSDirector/PDMR Transaction
1st Feb 20213:14 pmRNSTotal Voting Rights and Capital
6th Jan 20218:36 amRNSJasmine Whitbread - External Appointment
4th Jan 202111:51 amRNSTotal Voting Rights and Capital
17th Dec 20207:00 amRNSAccelerating Growth
17th Dec 20207:00 amRNSWPP AUNZ accepts revised proposal from WPP
15th Dec 20207:00 amRNSNotional cash pooling and net investment hedging
9th Dec 20204:30 pmRNSBoard Committee membership changes
4th Dec 20202:20 pmRNSDirectorate
1st Dec 202011:28 amRNSTotal Voting Rights and Capital
30th Nov 20207:00 amRNSProposal to acquire remaining shares in WPP AUNZ
27th Nov 202010:16 amRNSExecutive Performance Share Awards
17th Nov 20204:26 pmRNSDirector/PDMR Transaction
13th Nov 202011:00 amRNSDirector/PDMR Transaction
2nd Nov 202011:18 amRNSTotal Voting Rights and Capital
29th Oct 20207:00 amRNSThird Quarter Trading Update
26th Oct 20207:00 amRNSWPP appoints Dr. Ya-Qin Zhang to the Board
5th Oct 20207:00 amRNSWPP appoints Tom Ilube CBE to the Board
1st Oct 202011:21 amRNSTotal Voting Rights and Capital
30th Sep 202010:00 amRNSNotification of Trading Statement
24th Sep 20202:39 pmRNSDirector/PDMR Transaction
4th Sep 20207:00 amRNSAcquisition
1st Sep 20203:33 pmRNSTotal Voting Rights and Capital
27th Aug 20207:00 amRNS2020 Interim Results
18th Aug 202010:47 amRNSDirector's Dealing
5th Aug 202010:14 amRNSNotification of Major Holdings
3rd Aug 20207:00 amRNSTotal Voting Rights and Capital
1st Jul 202010:30 amRNSTotal Voting Rights and Capital
29th Jun 202010:59 amRNSNotice of 2020 Interim Results
18th Jun 20203:47 pmRNSDirector's Dealing
11th Jun 20206:24 pmRNS2020 AGM Board Retirements
11th Jun 20207:00 amRNSWPP appoints Angela Ahrendts DBE to the Board
10th Jun 20202:14 pmRNSResults of AGM
2nd Jun 202012:22 pmRNSShareholder Webcast - 10 June 2020
1st Jun 202012:09 pmRNSVoting Rights and Capital 31 May 2020
29th May 20205:52 pmRNSNotification of Major Holdings
15th May 202011:01 amRNSExecutive Share Awards
12th May 202010:31 amRNSDirector Declaration
11th May 202010:14 amRNSDirector's Dealing
4th May 20203:30 pmRNSBoard Retirement
1st May 202010:20 amRNSDirectors’ Interests
1st May 202010:04 amRNSVoting rights and Capital 30 April 2020
30th Apr 20202:50 pmRNSAnnual Report and Accounts 2019 and AGM 2020
29th Apr 20207:00 amRNSFirst Quarter Trading Update 2020
27th Apr 20205:47 pmRNSDisclosure of Rights Attached to Equity Shares
2nd Apr 20201:45 pmRNSVoting rights and Capital 31 March 2020
31st Mar 20207:00 amRNSUpdate re COVID-19
20th Mar 20207:00 amRNSTransaction in Own Shares
17th Mar 20207:00 amRNSTransaction in Own Shares
16th Mar 20207:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.